Patents by Inventor Peidong Fan

Peidong Fan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY WITH ADENOSINE RECEPTOR ANTAGONISTS
    Publication number: 20240041889
    Abstract: Disclosed herein are compounds, compositions, formulations, and methods for modulating the A2B adenosine receptor in combination with immune checkpoint inhibitors in mammals with cancer.
    Type: Application
    Filed: August 6, 2021
    Publication date: February 8, 2024
    Inventors: PEIDONG FAN, LINA YAO, JIWEN LIU, ELFATIH ELZEIN
  • METHODS FOR TREATING CARDIOVASCULAR DISEASES
    Publication number: 20180155447
    Abstract: Provided herein are methods that relate to a novel therapeutic strategy for treatment of heart and/or cardiovascular diseases. The method includes administration of LOXL2 inhibitors for treating, preventing, or ameliorating at least one symptom associated with heart and/or cardiovascular diseases.
    Type: Application
    Filed: October 19, 2017
    Publication date: June 7, 2018
    Inventors: Peidong Fan, Jong Kang, Amanda Mikels-Vigdal, Lina Yao, Hongyan Zhong
  • METHODS FOR TREATING CARDIOVASCULAR DISEASES
    Publication number: 20150361182
    Abstract: Provided herein are methods that relate to a novel therapeutic strategy for treatment of heart and/or cardiovascular diseases. The method includes administration of LOXL2 inhibitors for treating, preventing, or ameliorating at least one symptom associated with heart and/or cardiovascular diseases.
    Type: Application
    Filed: June 4, 2015
    Publication date: December 17, 2015
    Inventors: Peidong Fan, Jong Kang, Amanda Mikels-Vigdal, Lina Yao, Hongyan Zhong
  • COMBINATION THERAPY FOR THE TREATMENT OF ARRHYTHMIAS OR HEART FAILURE
    Publication number: 20140329755
    Abstract: The present invention relates to method of treating arrhythmias or heart failure comprising co-administration of a late INa inhibitor and a CAMK II inhibitor.
    Type: Application
    Filed: April 30, 2014
    Publication date: November 6, 2014
    Applicant: Gilead Sciences, Inc.
    Inventors: Luiz Belardinelli, Peidong Fan, Faquan Liang, Lina Yao
  • ALDH-2 inhibitors in the treatment of addiction
    Patent number: 8158810
    Abstract: Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: April 17, 2012
    Assignees: Gilead Sciences, Inc., The Endowment For Research in Human Biology, Inc.
    Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ, Yaroslav Bilokin, Elfatih Elzein, Tetsuya Kobayashi, Rao Kalla, Thao Perry, Xiaofen Li, Robert Jiang, Ivan Diamond, Lina Yao, Peidong Fan, Maria Pia Arolfo, Zhan Jiang, Wing Ming Keung, Guoxin Tao
  • ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION
    Publication number: 20090209533
    Abstract: Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.
    Type: Application
    Filed: February 13, 2009
    Publication date: August 20, 2009
    Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ, Yaroslav Bilokin, Elfatih Elzein, Tetsuya Kobayashi, Rao Kalla, Thao Perry, Xiaofen Li, Robert Jiang, Ivan Diamond, Lina Yao, Peidong Fan, Maria Pia Arolfo, Zhan Jiang, Wing Ming Keung, Guoxin Tao
  • ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION
    Publication number: 20080207610
    Abstract: Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.
    Type: Application
    Filed: January 24, 2008
    Publication date: August 28, 2008
    Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ, Yaroslav Bilokin, Robert Jiang, Elfatih Elzein, Tetsuya Kobayashi, Rao Kalla, Thao Perry, Xiaofen Li, Ivan Diamond, Lina Yao, Peidong Fan, Maria Pia Arolfo, Zhan Jiang
  • ALDH-2 INHIBITORS IN THE TREATMENT OF DRUG ADDICTION
    Publication number: 20080032995
    Abstract: Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.
    Type: Application
    Filed: July 27, 2007
    Publication date: February 7, 2008
    Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ, Yaroslav Bilokin, Ivan Diamond, Maria Arolfo, Lina Yao, Peidong Fan, Elfatih Elzein, Rao Kalla, Thao Perry, Tetsuya Kobayshi, Xiaofen Lee, Robert Jiang